Nearly 90% of life sciences manufacturers say digital transformation is necessary, and 58% have deployed smart manufacturing technologies at scale or across parts of their operations, according to Rockwell Automation Inc.’s The New Operating Model for Life Sciences Manufacturing: Moving from Compliance to Continuous Readiness report.
"Manufacturers used to treat regulatory readiness as a project, something they ramped up for," says Matt Weaver, VP, global industry, life sciences, Rockwell Automation. "Now, it has to be a daily discipline built into how the facility runs. The companies connecting their data, securing systems and validating AI deployments today are the ones that will be ready for what comes next from regulators or from the market."
Key takeaways:
· AI and machine learning (46%), process automation (44%) and cybersecurity (39%) are the technologies life sciences manufacturers expect to drive the biggest business outcomes. Manufacturers are prioritizing these investments to improve quality (43%), digitize operations (36%) and reduce risk (35%).
· Among manufacturers already using AI, 64% plan to expand its use within the next year, and 49% expect to increase investment over the next five years. Yet only 32% say they effectively use more than half the data they collect.
· 54% of life sciences organizations experienced at least one cyberattack in the past year, with the greatest exposure coming from IT systems and enterprise networks (41%), remote access and connected equipment (33%) and IT/OT integration points (29%).
